A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Kivu Bioscience Inc.
Kivu Bioscience Inc.
National Cancer Institute (NCI)
Eli Lilly and Company
OncoC4, Inc.
Seagen Inc.
KaliVir Immunotherapeutics
Arcus Biosciences, Inc.
Radiopharm Theranostics, Ltd
Sotio Biotech Inc.
Eli Lilly and Company
SystImmune Inc.
Rondo Therapeutics
M.D. Anderson Cancer Center
Orano Med LLC
Merck Sharp & Dohme LLC
ViroMissile, Inc.
Tizona Therapeutics, Inc
MacroGenics
SystImmune Inc.
Pheon Therapeutics
Eli Lilly and Company
Innate Pharma
Dren Bio
HiFiBiO Therapeutics
Incyte Corporation
Actym Therapeutics, Inc.
Chongqing Precision Biotech Co., Ltd
Nurix Therapeutics, Inc.
Pfizer
Arcus Biosciences, Inc.
GONGCHU Biotechnology Co., Ltd
Jonsson Comprehensive Cancer Center
Sichuan Enray Pharmaceutical Sciences Company
University of Virginia
Incyte Corporation
Anhui Provincial Hospital
NextPoint Therapeutics, Inc.
HC Biopharma Inc.
Turnstone Biologics, Corp.
Revolution Medicines, Inc.
Exelixis
Rutgers, The State University of New Jersey
Seagen Inc.
Seagen Inc.
Seagen Inc.
Anhui Provincial Hospital
Symphogen A/S
Vincerx Pharma, Inc.
Vincerx Pharma, Inc.
AstraZeneca